AllianceBernstein
ASMB icon

AllianceBernstein’s Assembly Biosciences ASMB Stock Holding History

AllianceBernstein’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2,133
Closed -$118K – 3326
2021
Q1 		$118K Sell
2,133
-359
-14% -$23.8K ﹤0.01% 3137
2020
Q4 		$181K Hold
2,492
– – ﹤0.01% 3018
2020
Q3 		$492K Sell
2,492
-66
-3% -$16.6K ﹤0.01% 2539
2020
Q2 		$716K Hold
2,558
– – ﹤0.01% 2386
2020
Q1 		$455K Hold
2,558
– – ﹤0.01% 2400
2019
Q4 		$628K Hold
2,558
– – ﹤0.01% 2454
2019
Q3 		$302K Buy
2,558
+208
+9% +$31.5K ﹤0.01% 2799
2019
Q2 		$380K Buy
2,350
+575
+32% +$109K ﹤0.01% 2728
2019
Q1 		$419K Buy
1,775
+117
+7% +$29.6K ﹤0.01% 2601
2018
Q4 		$450K Hold
1,658
– – ﹤0.01% 2529
2018
Q3 		$739K Hold
1,658
– – ﹤0.01% 2462
2018
Q2 		$780K Buy
1,658
+66
+4% +$34.9K ﹤0.01% 2425
2018
Q1 		$939K Buy
1,592
+592
+59% +$367K ﹤0.01% 2291
2017
Q4 		$543K Buy
+1,000
New +$453K ﹤0.01% 2505
2013
Q3 		– Hold
0
– – – 3460
2013
Q2 		– Hold
0
– – – 3248

Other funds holding ASMB

AIM
Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

AllianceBernstein's ASMB Position: Q2 2021 in Review

AllianceBernstein sold out of Assembly Biosciences (ASMB) in Q2 2021, closing a stake of 2,133 shares — an estimated $118K sold.

AllianceBernstein first reported a position in ASMB in Q4 2017 and held it in 14 quarters. The position peaked at $939K in Q1 2018. 91 funds tracked by Wall St. Rank hold ASMB as of Q2 2021.

  • AllianceBernstein reported no remaining Assembly Biosciences position as of Q2 2021 after selling out during the quarter.
  • AllianceBernstein sold 2,133 Assembly Biosciences shares in Q2 2021, an estimated $118K.
  • AllianceBernstein first reported a position in Assembly Biosciences in Q4 2017 and held it in 14 quarters.
  • AllianceBernstein's Assembly Biosciences position peaked at $939K in Q1 2018.
  • 91 funds tracked by Wall St. Rank held Assembly Biosciences as of Q2 2021.

Based on AllianceBernstein's 13F filing for Q2 2021, filed 30 Jul 2021.